Nephrosant, Inc
Kidney transplantation is the treatment of choice for patients with end-stage kidney failure. However, the life of a kidney transplant is limited due to unrecognized immune injury. There is no sensitive, non-invasive method to detect this injury at an early-stage. We have developed a reliable, inexpensive, and noninvasive assay to monitor kidney injury.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
3
51 to 200 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
4
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Nephrosant, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- PB
Peter Betzelos
() · Other
EmailPhone - LC
Lisa C.
Senior Director, Clinical Affairs · Healthcare & Human Services
EmailPhone - SH
Shih-Jwo Huang
Medical Director · Healthcare & Human Services
EmailPhone
Showing 3 of 3 verified contacts
Top roles at Nephrosant, Inc
3 distinct titles indexed · top 3 shown.
- 1()
- 1medical director
- 1senior director, clinical affairs
Sign up to unlock all 3 contacts at Nephrosant, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Nephrosant, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.